Skip to main content
Premium Trial:

Request an Annual Quote

Calendar of Meetings, Deadlines & Workshops: Mar 1, 2006

Premium

DATE CONFERENCE ORGANIZER LOCATION CATEGORY
MARCH
Mar 2-4 AUTM 2006 Annual Meeting AUTM Orlando Technology transfer  
Mar 5-9 45th Annual Society of Toxicology Conference SOT San Diego Toxicology  
Mar 5-10 Systems Biology: Integrating Biology, Technology, and Computation Keystone Symposia Taos, NM Systems biology
Mar 12-15 US HUPO Second Annual Symposium US HUPO Boston Proteomics
Mar 12-17 PITTCON PITTCON Orlando Chemistry/Spectroscopy
Mar 14-16 DDT Europe IBC Life Sciences London Pharma
Mar 22-23 RNAi 2006   Oxford, UK RNAi
Mar 22-24 Genomes to Systems Conference The Consortium for Post-Genome Science Manchester, UK Systems biology
Mar 22-24 ScreenTech IBC San Diego Pharma
Mar 23-26 2006 Annual Clinical Genetics Meeting ACMG San Diego Genetics  
Mar 24-25 World Microarray Congress   Vancouver, BC Arrays
Mar 26-30 231st National Meeting of the American Chemical Society ACS Atlanta Chemistry
Mar 29-Apr 1 3rd International Conference on Functional Genomics of Ageing Elsevier Palermo, Sicily Genomics
Mar 29-Apr 2 47th Annual Drosophila Research Conference   Houston General
APRIL
Apr 1-5 AACR 26th Annual Meeting AACR Washington, DC Cancer
Apr 1-5 Experimental Biology FASEB San Francisco Biology
Apr 2-5 RECOMB 2006 ACM-SIGACT Venice Bioinformatics
Apr 3-5 Life Sciences Conference + Expo 2006   Boston General
Apr 9-11 caBIG Annual Meeting caBIG Arlington, VA Cancer
Apr 9-12 BIO 2006 BIO Chicago General
Apr 9-13 3rd International Conference on Legume Genomics & Genetics ARC Centre of Excellence Brisbane, Australia Genomics
Apr 23-24 Systems Biology and Medicine ISB Seattle Systems biology
Apr 24-27 The GOT Summit CHI Boston Genomics
Apr 24-28 The Protein Engineering Summit CHI Boston Proteomics
Apr 27-28 OncoProteomics Select Conferences South San Francisco, CA Proteomics
MAY        
May 7-11 Emerging Genomic Biomarkers: Impact on Drug Discovery and Clinical Practice Keystone Symposia Victoria, British Columbia Pharma
May 7-11 Bio Nano 2006 Nano Science and Technology Inst. Boston General
May 10-14 The Biology of Genomes CSHL Cold Spring Harbor, NY Genomics
May 17-19 5th International Bio Expo Japan Reed Tokyo General
May 20-24 International Society for Analytical Cytology   Quebec City, Canada Cytology
May 21-25 106th American Society for Microbiology General Meeting ASM Orlando Microbiology
May 23-25 World Pharma Congress CHI Philadelphia Pharma
May 28-Jun 1 54th ASMS Conference on Mass Spectrometry ASMS Seattle Proteomics
May 31-Jun 3 HUGO Human Genome Meeting HUGO Helsinki, Finland Genomics
May 31-Jun 4 Oligonucleotide Therapeutics Society OTS Baltimore RNAi
JUNE        
Jun 2-6 42nd ASCO Annual Meeting ASCO Atlanta Cancer
Jun 7-9 Bangalore Bio 2006   Bangalore General
Jun 8-9 CAMDA 2006 CAMDA North Carolina Arrays
Jun 15-16 Structure-Based Drug Design CHI Boston Pharma
Jun 18-22 Drug Information Association 42nd Annual Meeting DIA Philadelphia Pharma
Jun 19-21 Beyond Genome CHI San Francisco Genomics
JULY
Jul 12-14 3rd Joint BSPR/EBI Proteomics Meeting British Society for Proteome Research Hinxton, UK Proteomics
AUGUST
Aug 5-9 20th Annual Symposium of the Protein Society Protein Society San Diego Proteomics
Aug 6-10 11th International Congress of Human Genetics Internat. Fed. of Human Genetics Societies Brisbane, Australia Genetics
Aug 6-10 ISMB 2006 ISCB Fortaleza, Brazil Bioinformatics
Aug 7-10 Drug Discovery Technology World Congress IBC Boston Drug discovery
SEPTEMBER
Sep 10-14 5th European Conference on Computational Biology 2006 Diesenhaus-Unitours Eilat, Israel Bioinformatics
Sep 10-14 232nd National Meeting of the American Chemical Society ACS San Francisco General    
Sep 17-21 Society for Biomolecular Sciences SBS Seattle Screening
Sep 25-28 Chips to Hits IBC Life Sciences Boston Microarrays
Sep 27-Oct 1 Genome Informatics   Hinxton, UK Bioinformatics
Sep 28-29 RNAi Europe   Prague RNAi
Sep 29-Oct 2 3rd Biologie Prospective Santorini Conference 2006 Biologie Prospective Santorini, Greece Pharmacogenomics

DEADLINES

March 10 — Deadline to submit applications for NHLBI Exploratory Program in Systems Biology, known also as RFA-HL-06-004.  NIH/NHLBI plans to award $24.3 million over the next five years to fund research combining computational and experimental approaches to improve understanding of heart, lung, blood, and sleep disorders.


March 11 — Letters of intent due for RFA-CA-07-005, Advanced Proteomic Platforms and Computational Sciences for the NCI Clinical Proteomic Technologies Initiative. NCI will commit around $10 million this year to fund approximately 10 grants for the quantitative analysis of proteins and peptides.

March 17 — Applications are due for the National Library of Medicine’s RFA-LM-06-001, Institutional Grants for Research Training in Biomedical Informatics.

March 27 — Full proposals are due from applicants to NSF 05-523, Assembling the Tree of Life. This project continues to support multidisciplinary teams investigating phylogenetic relationships for groups of organisms on the Tree of Life. Projects in data acquisition, analysis, algorithm development and dissemination in phyloinformatics will be funded.

April 11 — Formal applications are due for the NIH’s Genome Sequencing Centers, RFA-HG-06-001. This renewal of NHGRI’s large-scale sequencing program entails awards of up to $420 million in total costs over four years at not more than $130 million per year. The agencies expect to award three to five grants.

April 11 — Applications are due for the NCI Clinical Proteomic Technologies Initiative’s RFA-CA-07-005, Advanced Proteomic Platforms and Computational Sciences.  This funding initiative supports highly innovative research in the quantitative analysis of proteins and peptides of interest in clinical cancer studies.

April 26Due date for letters of intent regarding RFA-CA-07-002, Application of Emerging Technologies for Cancer Research, an NCI program for projects evaluating the emerging molecular technologies that are ready for application to cancer research questions. Applications are due May 26.

April 26 — Letters of intent due for RFA-CA-07-003, a program of the National Cancer Institute entitled Innovations in Cancer Sample Preparation.

April 26 — Letters of intent due for NCI’s RFA-CA-06-002, Innovative Technologies for Molecular Analysis of Cancer, which concerns research projects proposing the development of highly innovative cancer relevant molecular technologies.

May 26 — Deadline to submit applications for NCI’s Innovations in Cancer Sample Preparation, RFA-CA-07-003, which invites research projects involving the development and enhancement of cancer sample preparation methods and technologies.

May 26 — Applications are due for NCI’s Innovative Technologies for Molecular Analysis of Cancer, also known as RFA-CA-06-002.

June 1 — Deadline day for applications in response to program announcement PAR-05-163, Centers of Excellence in Genomics Science. NHGRI and NIMH intend to support 10 CEGS as P50 specialized centers and an unfixed number of projects under its P20 planning grant mechanism through 2007.

 

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.